• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login
    • Request Free Sample ×
    Molecular Diagnostics Market Research Report - Forecast till 2035 Infographic

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    Molecular Diagnostics Market

    ID: MRFR/MED/0665-CR
    200 Pages
    Rahul Gotadki
    July 2025

    Molecular Diagnostics Market Research Report By Application (Oncology, Infectious Diseases, Genetic Testing, Blood Screening, Other Applications), By Technology (Polymerase Chain Reaction, Next-Generation Sequencing, Microarrays, In Situ Hybridization, Other Technologies), By Product Type (Reagents, Instruments, Software, Consumables, Other Products), By End-user (Hospitals, Diagnostic Laboratories, Academic Institutions, Pharmaceutical Companies, Other End-users), and By Regional (North America, Europe, South America, Asia Pacific, Middle E...

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Molecular Diagnostics Market Research Report - Forecast till 2035 Infographic
    Purchase Options
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Compare License
    Table of Contents

    Molecular Diagnostics Market Summary

    As per Market Research Future Analysis, the Molecular Diagnostics Market was valued at 8.42 USD Billion in 2023 and is projected to grow to 19.2 USD Billion by 2035, reflecting a CAGR of 7.11% from 2025 to 2035. The market is driven by technological advancements, increasing incidence of infectious diseases, and the rise of personalized medicine.

    Key Market Trends & Highlights

    Key trends shaping the Molecular Diagnostics Market include technological innovations and a shift towards personalized healthcare.

    • The market is expected to reach 9.02 USD Billion in 2024, driven by advancements in diagnostic technologies.
    • Oncology applications are projected to be valued at 3.45 USD Billion in 2024, highlighting the importance of early cancer detection.
    • The Infectious Diseases segment is valued at 2.8 USD Billion in 2024, reflecting the urgent need for rapid diagnostics.
    • Personalized medicine initiatives are significantly influencing market growth, with increasing government support for research.

    Market Size & Forecast

    2023 Market Size USD 8.42 Billion
    2024 Market Size USD 9.02 Billion
    2035 Market Size USD 19.2 Billion
    CAGR (2025-2035) 7.11%

    Major Players

    Key players include Abbott Laboratories, Luminex Corporation, Myriad Genetics, Becton Dickinson and Company, Thermo Fisher Scientific, BioMerieux SA, Genomic Health, Danaher Corporation, Roche Holding AG, Illumina, Inc.

    Molecular Diagnostics Market Trends

    The growing need for precise and quick diagnostic techniques is driving notable developments in the Molecular Diagnostics Market. Technological developments like digital PCR and next-generation sequencing are improving the accuracy of diagnostic procedures.

    Because these technologies make it possible to identify specific genetic material linked to different disorders, they are essential for early disease diagnosis, especially in infectious diseases and cancer. Additionally, the market is being driven by the increased focus on customized medicine, as medical professionals look for tests that can inform patient-specific treatment regimens.

    There are several opportunities to explore the Molecular Diagnostics Market, especially with the growing popularity of point-of-care testing. This method enables quick testing in a variety of contexts, which eases the strain on labs and provides patients and healthcare providers with instant findings.

    Furthermore, there is a significant chance to improve the precision and effectiveness of molecular testing due to the growing integration of AI and machine learning in diagnostic procedures. The industry has also emphasized the significance of thorough regulatory structures in recent years.

    In order to guarantee the safety and efficacy of molecular diagnostic tools, governments and health organizations are realizing the necessity for precise regulations. Furthermore, the need for strong molecular diagnostics has been highlighted by the COVID-19 pandemic, which has raised funding for research and development.Innovations and more partnerships between the public and commercial sectors have resulted from this. 

    A move toward more advanced and prompt healthcare solutions that meet the demands of a wide range of patients is reflected in the expansion and development of the Molecular Diagnostics Market.

    The Global Molecular Diagnostics Market is poised for robust growth, driven by advancements in technology and an increasing demand for personalized medicine, which collectively enhance diagnostic accuracy and patient outcomes.

    U.S. Food and Drug Administration (FDA)

    Molecular Diagnostics Market Drivers

    Rising Prevalence of Chronic Diseases

    The increasing incidence of chronic diseases such as cancer, diabetes, and cardiovascular disorders is a primary driver of the Global Molecular Diagnostics Market Industry. As healthcare systems worldwide grapple with the burden of these conditions, molecular diagnostics offer precise and timely detection methods. For instance, the market is projected to reach 9.02 USD Billion in 2024, reflecting a growing demand for advanced diagnostic tools. This trend is likely to continue as the global population ages and the prevalence of these diseases rises, necessitating innovative solutions that molecular diagnostics can provide.

    Market Segment Insights

    Molecular Diagnostics Market Application Insights

    The Molecular Diagnostics Market experienced significant growth, with remarkable expansion across various applications, showcasing its diverse potential in the healthcare sector. The overall market indicated strong demand for molecular diagnostics in areas such as oncology, infectious diseases, genetic testing, blood screening, and other applications.

    The Oncology application held a major share of the market, expected to be valued at 3.6 USD Billion in 2024 and rising to 7.5 USD Billion by 2035, highlighting its critical role in early cancer detection and personalized therapy, which had a considerable impact on treatment outcomes.

    The segment of Infectious Diseases followed closely, with a valuation of 2.6 USD Billion in 2024, projected to grow to 5.5 USD Billion by 2035, reflecting the rising need for rapid and accurate infection diagnostics, particularly in the wake of global health crises.Genetic Testing, valued at 1.5 USD Billion in 2024 and anticipated to reach 4.0 USD Billion in 2035, underscored the growing emphasis on precision medicine and hereditary risk assessments, providing invaluable insights into patient care and management.

    Blood Screening was also an important application, with a market value of 0.9 USD Billion in 2024, expected to double to 1.8 USD Billion by 2035, driven by advancements in blood safety and disease prevention strategies. Other Applications, while smaller in size at 0.42 USD Billion in 2024, demonstrated ongoing innovation in molecular diagnostics, enhancing the overall diagnostic landscape.

    The demand across these applications was fueled by various growth drivers, including technological advancements, increasing healthcare expenditure, and the rising prevalence of chronic diseases globally. Moreover, challenges such as regulatory hurdles and the high cost of tests could impact market trajectory, presenting opportunities for stakeholders to develop cost-effective solutions.

    Collectively, the Molecular Diagnostics Market segmentation emphasized significant growth potential in critical areas, driven by the need for precision and efficiency in healthcare delivery, ultimately transforming patient management and diagnosis on a global scale.

    The rising awareness about the benefits of molecular diagnostics was also a vital factor in market growth, ensuring that professionals leverage these tools for improved patient outcomes.

    Molecular Diagnostics Market Technology Insights

    The market is characterized by the rapid advancement of technology, with key methodologies that shape its landscape. Notably, Polymerase Chain Reaction technology continues to play a crucial role due to its ability to amplify targeted DNA sequences, making it indispensable for various applications in diagnostics.

    Next-Generation Sequencing has also emerged as a powerful tool, allowing for the comprehensive analysis of genetic material at an unprecedented scale, facilitating personalized medicine. Microarrays enable the simultaneous tracking of thousands of genes, thus providing valuable insights in genomics and oncology.

    In Situ Hybridization is significant for its ability to visualize and locate specific nucleic acid sequences, essential in research and clinical diagnostics. Other Technologies under this segment include a variety of innovative methods contributing to the industry's growth.

    The integration of these technologies boosts the Molecular Diagnostics Market data, reflecting robust market growth driven by increasing incidences of chronic diseases and advancements in healthcare diagnostics.

    The market statistics indicate that the continuous innovation in molecular diagnostics enhances capabilities and fosters greater precision in disease detection and management globally.

    Molecular Diagnostics Market Product Type Insights

    The Molecular Diagnostics Market is experiencing significant growth. This growth can be attributed to a rising demand for accurate and rapid diagnostic tools, driving innovation in technology and processes.

    Within the realm of Product Type, the market encompasses various segments, including Reagents, Instruments, Software, Consumables, and Other Products. Notably, reagents play a crucial role in ensuring accurate molecular analyses and serve as the backbone of many diagnostic procedures.

    Instruments designed for molecular diagnostics are also vital, enabling precise test execution with efficient turnaround times. The Software segment provides essential support in data management, processing, and interpretation of diagnostic results, which is increasingly important as labs move towards automation and more complex analytical processes.

    Consumables, being an integral part of routine diagnostics, aid in maintaining lab workflows, while Other Products address specific niche applications within the molecular landscape.

    As healthcare continues to prioritize personalized medicine and genomic insights, the Molecular Diagnostics Market will likely see further diversification and advancement across these Product Type segments, driven by ongoing Research and Development efforts and an increasing focus on disease prevention and management strategies.

    Molecular Diagnostics Market End-user Insights

    The Molecular Diagnostics Market is poised for considerable growth, particularly driven by its diverse End-user segment, which includes Hospitals, Diagnostic Laboratories, Academic Institutions, Pharmaceutical Companies, and Other End-users.

    Hospitals play a crucial role as they require accurate and timely diagnostics for patient management, while Diagnostic Laboratories are increasingly adopting advanced technologies to enhance testing efficiency.

    Academic Institutions contribute significantly by conducting Research and Development activities that foster innovation in molecular diagnostics. Pharmaceutical Companies leverage molecular diagnostics for drug development and personalized medicine, showcasing the technology’s utility in treatment optimization.

    The array of Other End-users further illustrates the market's breadth and adaptability across health care and research sectors, all of which are integral to the advancement of the Molecular Diagnostics Market. This segmentation highlights the importance of each End-user in driving market growth and developing solutions tailored to specific healthcare needs.

    Get more detailed insights about Molecular Diagnostics Market Research Report - Forecast till 2035

    Request Free Sample

    Regional Insights

    The Molecular Diagnostics Market showed significant growth potential across various regions, poised to cater to the rising demand for precision medicine and advanced diagnostic techniques. North America led with a valuation of 3.7 USD Billion in 2024, reflecting the region's majority holding due to its advanced healthcare infrastructure and strong investment in Research and Development.

    Europe followed, valued at 2.5 USD Billion in the same year, driven by increasing awareness and supportive healthcare policies. In South America, the market stood at 0.8 USD Billion, showcasing potential for expansion as awareness of molecular diagnostics grows, while Asia Pacific, with a valuation of 1.7 USD Billion, benefits from a vast population and increasing healthcare expenditure.

    The Middle East and Africa, although smaller with a valuation of 0.32 USD Billion, had an emerging market driven by rising healthcare initiatives and improving access to diagnostic technologies.Overall, the Molecular Diagnostics Market segmentation highlighted regional disparities and significant opportunities for market growth, as varied factors like population demographics and healthcare systems influence market dynamics.

    Molecular Diagnostics Market Regional Insights

    Source: Primary Research, Secondary Research, Market Research Future Database and Analyst Review

    Key Players and Competitive Insights

    The Molecular Diagnostics Market has experienced significant growth due to advancements in technology and an increasing focus on personalized medicine. This market segment is characterized by the application of molecular biology techniques for the diagnosis and monitoring of various diseases, particularly infectious diseases and genetic disorders.

    As healthcare providers and patients alike prioritize precise and rapid diagnostic solutions, companies operating in this sector are vying for market share through innovative product development, strategic partnerships, and expansive distribution networks.

    The competitive landscape is shaped by key players who leverage their capabilities in research and development to introduce novel testing solutions that meet the evolving demands of the healthcare market.Becton Dickinson has established a strong presence in the Molecular Diagnostics Market through its extensive portfolio of diagnostic solutions that cater to the needs of healthcare professionals. The company’s commitment to innovation is evident in its investment in research and development, which has resulted in a range of advanced molecular diagnostic tools for rapid and accurate healthcare delivery.

    Becton Dickinson's strengths lie in its robust manufacturing capabilities, extensive distribution network, and strategic collaborations with healthcare institutions and laboratories.These attributes not only bolster its market positioning but also allow the company to effectively respond to the diverse needs of customers in various regions around the globe, thereby fostering strong relationships and enhancing customer loyalty.

    Thermo Fisher Scientific plays a crucial role in the Molecular Diagnostics Market, offering a comprehensive range of products that include reagents, instruments, and software designed for molecular analysis.

    The company’s strengths are grounded in its extensive research and development expertise, which fosters the creation of innovative diagnostic solutions that address critical clinical needs. Thermo Fisher Scientific maintains a solid market presence through strategic mergers and acquisitions that expand its product offerings and enhance its technological capabilities.

    This approach enables the company to provide cutting-edge solutions to laboratories and healthcare providers, facilitating timely and accurate diagnostics. Furthermore, Thermo Fisher's dedication to quality and service excellence helps establish it as a trusted partner in the molecular diagnostics landscape, ultimately leading to improved patient outcomes on a global scale.

    Key Companies in the Molecular Diagnostics Market market include

    Industry Developments

    Abbott confirmed that its fast antigen and PCR assays consistently detect new variants including KP.2, KP.3, and KP.1.1 through its long-standing Viral Surveillance Program; Abbott revealed improvements to its COVID-19 molecular diagnostics tests on July 26, 2024. Abbott launched the interpretable droplet digital PCR (I2ddPCR) assay on January 16, 2025.By combining a GPT-4o multimodal model with AI-based image processing, the assay achieved 99.05% accuracy in ddPCR testing for low-abundance targets at about 90 copies/µL.

    Abbott announced its Q1 2025 results on April 16, 2025, which showed that sales of molecular diagnostics totaled $122 million worldwide, a 5.9% year-over-year fall mainly due to lower demand for COVID testing, whereas regular molecular testing was stable in foreign markets.

    On the heels of the FDA's approval of its i-STAT TBI cartridge in Q1 2024 and the inclusion of GLP TrackTM lab automation in Q4 2023, the business announced the extension of its Alinity molecular testing range. A novel CRISPR-Cas12a diagnostics technique using machine learning and statistical classifiers was released by academic researchers on January 8, 2025.

    This method greatly increases speed and accuracy, with one LSTM model obtaining 100% specificity. Lastly, another scholarly study described AI-enhanced digital NAAT systems, including dPCR and dLAMP, merging image analytics for accuracy, throughput, and point-of-care preparedness on July 30, 2024.

    Future Outlook

    Molecular Diagnostics Market Future Outlook

    The Global Molecular Diagnostics Market is projected to grow at a 7.11% CAGR from 2024 to 2035, driven by technological advancements, increasing demand for personalized medicine, and rising prevalence of infectious diseases.

    New opportunities lie in:

    • Develop next-generation sequencing platforms for rapid diagnostics.
    • Invest in point-of-care testing solutions to enhance accessibility.
    • Leverage AI and machine learning for data analysis and interpretation.

    By 2035, the market is expected to reach a robust position, reflecting substantial growth and innovation.

    Market Segmentation

    Molecular Diagnostics Market End-user Outlook

    • Hospitals
    • Diagnostic Laboratories
    • Academic Institutions
    • Pharmaceutical Companies
    • Other End-users

    Molecular Diagnostics Market Regional Outlook

    • North America
    • Europe
    • South America
    • Asia Pacific
    • Middle East and Africa

    Molecular Diagnostics Market Technology Outlook

    • Polymerase Chain Reaction
    • Next-Generation Sequencing
    • Microarrays
    • In Situ Hybridization
    • Other Technologies

    Molecular Diagnostics Market Application Outlook

    • Oncology
    • Infectious Diseases
    • Genetic Testing
    • Blood Screening
    • Other Applications

    Molecular Diagnostics Market Product Type Outlook

    • Reagents
    • Instruments
    • Software
    • Consumables
    • Other Products

    Report Scope

    Report Attribute/Metric

    Details

    Market Size 2023

    8.42(USD Billion)

    Market Size 2024

    9.02(USD Billion)

    Market Size 2035

    19.2(USD Billion)

    Compound Annual Growth Rate (CAGR)

    7.11% (2025 - 2035)

    Report Coverage

    Revenue Forecast, Competitive Landscape, Growth Factors, and Trends

    Base Year

    2024

    Market Forecast Period

    2025 - 2035

    Historical Data

    2019 - 2024

    Market Forecast Units

    USD Billion

    Key Companies Profiled

    Becton Dickinson, Thermo Fisher Scientific, PerkinElmer, Roche Diagnostics, Hologic, Siemens Healthineers, Genomic Health, Cepheid, Exact Sciences, Qiagen, Myriad Genetics, Illumina, Agilent Technologies, Abbott Laboratories, BioRad Laboratories

    Segments Covered

    Application, Technology, Product Type, End-user, Regional

    Key Market Opportunities

    Rapid growth in point-of-care testing, Expanding personalized medicine applications, Advancements in PCR technology, Increasing demand for genetic testing, Growth of companion diagnostics market

    Key Market Dynamics

    Technological advancements, Increasing prevalence of diseases, Rising demand for personalized medicine, Growing awareness of early diagnosis, Enhanced regulatory support for diagnostics

    Countries Covered

    North America, Europe, APAC, South America, MEA

    Market Highlights

    Author
    Rahul Gotadki
    Assistant Manager

    He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

    Get In Touch
    Leave a Comment

    FAQs

    What was the market size for the Molecular Diagnostics Market in 2024?

    The Molecular Diagnostics Market was valued at 9.02 billion USD in 2024.

    What will the market value of the Molecular Diagnostics Market be by 2035?

    By 2035, the Molecular Diagnostics Market is expected to reach a value of 19.2 billion USD.

    What is the expected CAGR for the Molecular Diagnostics Market from 2025 to 2035?

    The expected CAGR for the Molecular Diagnostics Market from 2025 to 2035 is 7.11%.

    Which region held the largest market share in 2024?

    North America held the largest market share, valued at 3.7 billion USD in 2024.

    What are the expected market values for the oncology segment in 2024 and 2035?

    The oncology segment was valued at 3.6 billion USD in 2024 and is expected to reach 7.5 billion USD in 2035.

    What was the market value for the infectious diseases segment in 2024?

    In 2024, the market value for the infectious diseases segment was 2.6 billion USD.

    Who are the key players in the Molecular Diagnostics Market?

    Key players in the market include Becton Dickinson, Thermo Fisher Scientific, and Roche Diagnostics, among others.

    How is the market for genetic testing projected to grow between 2024 and 2035?

    The genetic testing market is expected to grow from 1.5 billion USD in 2024 to 4.0 billion USD by 2035.

    What is the projected market value for the Asia Pacific region in 2035?

    The Asia Pacific region is projected to reach a market value of 3.8 billion USD by 2035.

    What challenges might the Molecular Diagnostics Market face in the coming years?

    The market may face challenges such as regulatory hurdles and the need for technological advancements.

    1. EXECUTIVE SUMMARY
      1. Market Overview
      2. Key Findings
      3. Market Segmentation
      4. Competitive Landscape
      5. Challenges and Opportunities
    2. Future Outlook
    3. MARKET INTRODUCTION
      1. Definition
      2. Scope of the study
        1. Research Objective
        2. Assumption
        3. Limitations
    4. RESEARCH METHODOLOGY
      1. Overview
    5. Data Mining
      1. Secondary Research
      2. Primary Research
    6. Primary Interviews and Information Gathering Process
      1. Breakdown of Primary
    7. Respondents
      1. Forecasting Model
      2. Market Size Estimation
    8. Bottom-Up Approach
      1. Top-Down Approach
      2. Data Triangulation
      3. Validation
    9. MARKET DYNAMICS
      1. Overview
      2. Drivers
      3. Restraints
      4. Opportunities
    10. MARKET FACTOR ANALYSIS
      1. Value chain Analysis
      2. Porter's Five Forces
    11. Analysis
      1. Bargaining Power of Suppliers
        1. Bargaining Power
    12. of Buyers
      1. Threat of New Entrants
        1. Threat of Substitutes
        2. Intensity of Rivalry
      2. COVID-19 Impact Analysis
    13. Market Impact Analysis
      1. Regional Impact
        1. Opportunity and
    14. Threat Analysis
    15. MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION
    16. (USD BILLION)
      1. Oncology
      2. Infectious Diseases
      3. Genetic
    17. Testing
      1. Blood Screening
      2. Other Applications
    18. MOLECULAR
    19. DIAGNOSTICS MARKET, BY TECHNOLOGY (USD BILLION)
      1. Polymerase Chain Reaction
      2. Next-Generation Sequencing
      3. Microarrays
      4. In Situ
    20. Hybridization
      1. Other Technologies
    21. MOLECULAR DIAGNOSTICS MARKET,
    22. BY PRODUCT TYPE (USD BILLION)
      1. Reagents
      2. Instruments
    23. Software
      1. Consumables
      2. Other Products
    24. MOLECULAR DIAGNOSTICS
    25. MARKET, BY END USER (USD BILLION)
      1. Hospitals
      2. Diagnostic Laboratories
      3. Academic Institutions
      4. Pharmaceutical Companies
    26. Other End Users
    27. MOLECULAR DIAGNOSTICS MARKET, BY REGIONAL (USD BILLION)
      1. North America
        1. US
        2. Canada
      2. Europe
        1. Germany
        2. UK
        3. France
        4. Russia
        5. Italy
        6. Spain
        7. Rest of Europe
    28. APAC
      1. China
        1. India
        2. Japan
        3. South
    29. Korea
      1. Malaysia
        1. Thailand
        2. Indonesia
        3. Rest of APAC
      2. South America
        1. Brazil
    30. Mexico
      1. Argentina
        1. Rest of South America
      2. MEA
        1. GCC Countries
        2. South Africa
        3. Rest of MEA
    31. COMPETITIVE LANDSCAPE
      1. Overview
    32. Competitive Analysis
      1. Market share Analysis
      2. Major Growth
    33. Strategy in the Molecular Diagnostics Market
      1. Competitive Benchmarking
      2. Leading Players in Terms of Number of Developments in the Molecular
    34. Diagnostics Market
      1. Key developments and growth strategies
    35. New Product Launch/Service Deployment
      1. Merger & Acquisitions
        1. Joint Ventures
      2. Major Players Financial Matrix
    36. Sales and Operating Income
      1. Major Players R&D Expenditure. 2023
    37. COMPANY PROFILES
      1. Abbott Laboratories
        1. Financial
    38. Overview
      1. Products Offered
        1. Key Developments
    39. SWOT Analysis
      1. Key Strategies
      2. Luminex Corporation
    40. Financial Overview
      1. Products Offered
        1. Key Developments
        2. SWOT Analysis
        3. Key Strategies
      2. Myriad Genetics
        1. Financial Overview
        2. Products Offered
        3. Key
    41. Developments
      1. SWOT Analysis
        1. Key Strategies
    42. Becton Dickinson and Company
      1. Financial Overview
        1. Products
    43. Offered
      1. Key Developments
        1. SWOT Analysis
    44. Key Strategies
      1. Thermo Fisher Scientific
        1. Financial Overview
        2. Products Offered
        3. Key Developments
        4. SWOT
    45. Analysis
      1. Key Strategies
      2. BioMerieux SA
        1. Financial
    46. Overview
      1. Products Offered
        1. Key Developments
    47. SWOT Analysis
      1. Key Strategies
      2. Genomic Health
    48. Financial Overview
      1. Products Offered
        1. Key Developments
        2. SWOT Analysis
        3. Key Strategies
      2. Danaher Corporation
        1. Financial Overview
        2. Products Offered
        3. Key
    49. Developments
      1. SWOT Analysis
        1. Key Strategies
    50. Roche Holding AG
      1. Financial Overview
        1. Products Offered
        2. Key Developments
        3. SWOT Analysis
        4. Key Strategies
      2. Illumina, Inc.
        1. Financial Overview
        2. Products
    51. Offered
      1. Key Developments
        1. SWOT Analysis
    52. Key Strategies
      1. Asuragen, Inc.
        1. Financial Overview
        2. Products Offered
        3. Key Developments
        4. SWOT
    53. Analysis
      1. Key Strategies
      2. Agilent Technologies
    54. Financial Overview
      1. Products Offered
        1. Key Developments
        2. SWOT Analysis
        3. Key Strategies
      2. Hologic,
    55. Inc.
      1. Financial Overview
        1. Products Offered
    56. Key Developments
      1. SWOT Analysis
        1. Key Strategies
      2. Qiagen N.V.
        1. Financial Overview
        2. Products Offered
        3. Key Developments
        4. SWOT Analysis
        5. Key
    57. Strategies
    58. APPENDIX
      1. References
      2. Related Reports
    59. AMERICA MOLECULAR DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION,
    60. 2035 (USD BILLIONS)
    61. SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2035 (USD BILLIONS)
    62. NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY
    63. PRODUCT TYPE, 2019-2035 (USD BILLIONS)
    64. MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)
    65. BY REGIONAL, 2019-2035 (USD BILLIONS)
    66. SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
    67. US MOLECULAR DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY,
    68. 2035 (USD BILLIONS)
    69. & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS)
    70. DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)
    71. REGIONAL, 2019-2035 (USD BILLIONS)
    72. MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
    73. TECHNOLOGY, 2019-2035 (USD BILLIONS)
    74. MARKET SIZE ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS)
    75. BY END USER, 2019-2035 (USD BILLIONS)
    76. MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
    77. APPLICATION, 2019-2035 (USD BILLIONS)
    78. MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2035 (USD BILLIONS)
    79. PRODUCT TYPE, 2019-2035 (USD BILLIONS)
    80. MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)
    81. REGIONAL, 2019-2035 (USD BILLIONS)
    82. MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
    83. BY TECHNOLOGY, 2019-2035 (USD BILLIONS)
    84. MARKET SIZE ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS)
    85. BY END USER, 2019-2035 (USD BILLIONS)
    86. MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
    87. 2035 (USD BILLIONS)
    88. & FORECAST, BY TECHNOLOGY, 2019-2035 (USD BILLIONS)
    89. DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD
    90. BILLIONS)
    91. BY END USER, 2019-2035 (USD BILLIONS)
    92. SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
    93. FRANCE MOLECULAR DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION,
    94. 2035 (USD BILLIONS)
    95. ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2035 (USD BILLIONS)
    96. FRANCE MOLECULAR DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY PRODUCT TYPE,
    97. 2035 (USD BILLIONS)
    98. ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)
    99. FRANCE MOLECULAR DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL,
    100. 2035 (USD BILLIONS)
    101. ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
    102. RUSSIA MOLECULAR DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY,
    103. 2035 (USD BILLIONS)
    104. ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS)
    105. RUSSIA MOLECULAR DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY END USER,
    106. 2035 (USD BILLIONS)
    107. ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
    108. ITALY MOLECULAR DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION,
    109. 2035 (USD BILLIONS)
    110. ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2035 (USD BILLIONS)
    111. ITALY MOLECULAR DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY PRODUCT TYPE,
    112. 2035 (USD BILLIONS)
    113. ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)
    114. ITALY MOLECULAR DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035
    115. (USD BILLIONS)
    116. & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
    117. DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2035 (USD
    118. BILLIONS)
    119. FORECAST, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS)
    120. DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)
    121. BY REGIONAL, 2019-2035 (USD BILLIONS)
    122. MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
    123. BY TECHNOLOGY, 2019-2035 (USD BILLIONS)
    124. DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD
    125. BILLIONS)
    126. & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)
    127. MOLECULAR DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035
    128. (USD BILLIONS)
    129. & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
    130. DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2035 (USD
    131. BILLIONS)
    132. FORECAST, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS)
    133. DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)
    134. BY REGIONAL, 2019-2035 (USD BILLIONS)
    135. MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
    136. TECHNOLOGY, 2019-2035 (USD BILLIONS)
    137. MARKET SIZE ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS)
    138. BY END USER, 2019-2035 (USD BILLIONS)
    139. MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
    140. APPLICATION, 2019-2035 (USD BILLIONS)
    141. MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2035 (USD BILLIONS)
    142. PRODUCT TYPE, 2019-2035 (USD BILLIONS)
    143. MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)
    144. REGIONAL, 2019-2035 (USD BILLIONS)
    145. SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
    146. JAPAN MOLECULAR DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY,
    147. 2035 (USD BILLIONS)
    148. ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS)
    149. JAPAN MOLECULAR DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY END USER,
    150. 2035 (USD BILLIONS)
    151. ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
    152. SOUTH KOREA MOLECULAR DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION,
    153. 2035 (USD BILLIONS)
    154. SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2035 (USD BILLIONS)
    155. SOUTH KOREA MOLECULAR DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY PRODUCT
    156. TYPE, 2019-2035 (USD BILLIONS)
    157. MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)
    158. BY REGIONAL, 2019-2035 (USD BILLIONS)
    159. MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
    160. BY TECHNOLOGY, 2019-2035 (USD BILLIONS)
    161. MARKET SIZE ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS)
    162. BY END USER, 2019-2035 (USD BILLIONS)
    163. MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
    164. BY APPLICATION, 2019-2035 (USD BILLIONS)
    165. MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2035 (USD BILLIONS)
    166. BY PRODUCT TYPE, 2019-2035 (USD BILLIONS)
    167. MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)
    168. BY REGIONAL, 2019-2035 (USD BILLIONS)
    169. MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
    170. BY TECHNOLOGY, 2019-2035 (USD BILLIONS)
    171. MARKET SIZE ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS)
    172. BY END USER, 2019-2035 (USD BILLIONS)
    173. MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
    174. BY APPLICATION, 2019-2035 (USD BILLIONS)
    175. DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2035 (USD
    176. BILLIONS)
    177. & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS)
    178. OF APAC MOLECULAR DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY END USER,
    179. 2035 (USD BILLIONS)
    180. SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
    181. SOUTH AMERICA MOLECULAR DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY
    182. APPLICATION, 2019-2035 (USD BILLIONS)
    183. MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2035 (USD BILLIONS)
    184. BY PRODUCT TYPE, 2019-2035 (USD BILLIONS)
    185. DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)
    186. FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
    187. DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD
    188. BILLIONS)
    189. FORECAST, BY TECHNOLOGY, 2019-2035 (USD BILLIONS)
    190. DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD
    191. BILLIONS)
    192. FORECAST, BY END USER, 2019-2035 (USD BILLIONS)
    193. DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
    194. BY APPLICATION, 2019-2035 (USD BILLIONS)
    195. MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2035 (USD BILLIONS)
    196. BY PRODUCT TYPE, 2019-2035 (USD BILLIONS)
    197. MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)
    198. BY REGIONAL, 2019-2035 (USD BILLIONS)
    199. MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
    200. BY TECHNOLOGY, 2019-2035 (USD BILLIONS)
    201. MARKET SIZE ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS)
    202. BY END USER, 2019-2035 (USD BILLIONS)
    203. MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
    204. FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
    205. AMERICA MOLECULAR DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY,
    206. 2035 (USD BILLIONS)
    207. MARKET SIZE ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS)
    208. & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)
    209. AMERICA MOLECULAR DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL,
    210. 2035 (USD BILLIONS)
    211. ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
    212. MEA MOLECULAR DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2035
    213. (USD BILLIONS)
    214. & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS)
    215. DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)
    216. BY REGIONAL, 2019-2035 (USD BILLIONS)
    217. MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
    218. BY TECHNOLOGY, 2019-2035 (USD BILLIONS)
    219. DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD
    220. BILLIONS)
    221. & FORECAST, BY END USER, 2019-2035 (USD BILLIONS)
    222. MOLECULAR DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035
    223. (USD BILLIONS)
    224. & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS)
    225. AFRICA MOLECULAR DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY,
    226. 2035 (USD BILLIONS)
    227. SIZE ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS)
    228. SOUTH AFRICA MOLECULAR DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY
    229. END USER, 2019-2035 (USD BILLIONS)
    230. MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
    231. BY APPLICATION, 2019-2035 (USD BILLIONS)
    232. DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY TECHNOLOGY, 2019-2035 (USD
    233. BILLIONS)
    234. & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS)
    235. OF MEA MOLECULAR DIAGNOSTICS MARKET SIZE ESTIMATES & FORECAST, BY END USER,
    236. 2035 (USD BILLIONS)
    237. SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS)
    238. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
    239. NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET ANALYSIS
    240. DIAGNOSTICS MARKET ANALYSIS BY APPLICATION
    241. MARKET ANALYSIS BY TECHNOLOGY
    242. BY PRODUCT TYPE
    243. USER
    244. CANADA MOLECULAR DIAGNOSTICS MARKET ANALYSIS BY APPLICATION
    245. MOLECULAR DIAGNOSTICS MARKET ANALYSIS BY TECHNOLOGY
    246. DIAGNOSTICS MARKET ANALYSIS BY PRODUCT TYPE
    247. MARKET ANALYSIS BY END USER
    248. ANALYSIS BY REGIONAL
    249. GERMANY MOLECULAR DIAGNOSTICS MARKET ANALYSIS BY PRODUCT TYPE
    250. GERMANY MOLECULAR DIAGNOSTICS MARKET ANALYSIS BY END USER
    251. MOLECULAR DIAGNOSTICS MARKET ANALYSIS BY REGIONAL
    252. DIAGNOSTICS MARKET ANALYSIS BY APPLICATION
    253. MARKET ANALYSIS BY TECHNOLOGY
    254. BY PRODUCT TYPE
    255. USER
    256. FRANCE MOLECULAR DIAGNOSTICS MARKET ANALYSIS BY APPLICATION
    257. FRANCE MOLECULAR DIAGNOSTICS MARKET ANALYSIS BY TECHNOLOGY
    258. MOLECULAR DIAGNOSTICS MARKET ANALYSIS BY PRODUCT TYPE
    259. DIAGNOSTICS MARKET ANALYSIS BY END USER
    260. MARKET ANALYSIS BY REGIONAL
    261. ANALYSIS BY APPLICATION
    262. BY TECHNOLOGY
    263. TYPE
    264. ITALY MOLECULAR DIAGNOSTICS MARKET ANALYSIS BY APPLICATION
    265. ITALY MOLECULAR DIAGNOSTICS MARKET ANALYSIS BY TECHNOLOGY
    266. MOLECULAR DIAGNOSTICS MARKET ANALYSIS BY PRODUCT TYPE
    267. DIAGNOSTICS MARKET ANALYSIS BY END USER
    268. MARKET ANALYSIS BY REGIONAL
    269. ANALYSIS BY APPLICATION
    270. BY TECHNOLOGY
    271. TYPE
    272. REST OF EUROPE MOLECULAR DIAGNOSTICS MARKET ANALYSIS BY APPLICATION
    273. REST OF EUROPE MOLECULAR DIAGNOSTICS MARKET ANALYSIS BY TECHNOLOGY
    274. REST OF EUROPE MOLECULAR DIAGNOSTICS MARKET ANALYSIS BY PRODUCT TYPE
    275. REST OF EUROPE MOLECULAR DIAGNOSTICS MARKET ANALYSIS BY END USER
    276. REST OF EUROPE MOLECULAR DIAGNOSTICS MARKET ANALYSIS BY REGIONAL
    277. APAC MOLECULAR DIAGNOSTICS MARKET ANALYSIS
    278. DIAGNOSTICS MARKET ANALYSIS BY APPLICATION
    279. MARKET ANALYSIS BY TECHNOLOGY
    280. ANALYSIS BY PRODUCT TYPE
    281. BY END USER
    282. INDIA MOLECULAR DIAGNOSTICS MARKET ANALYSIS BY PRODUCT TYPE
    283. INDIA MOLECULAR DIAGNOSTICS MARKET ANALYSIS BY END USER
    284. DIAGNOSTICS MARKET ANALYSIS BY REGIONAL
    285. MARKET ANALYSIS BY APPLICATION
    286. ANALYSIS BY TECHNOLOGY
    287. BY PRODUCT TYPE
    288. END USER
    289. MALAYSIA MOLECULAR DIAGNOSTICS MARKET ANALYSIS BY APPLICATION
    290. MALAYSIA MOLECULAR DIAGNOSTICS MARKET ANALYSIS BY TECHNOLOGY
    291. MOLECULAR DIAGNOSTICS MARKET ANALYSIS BY PRODUCT TYPE
    292. MOLECULAR DIAGNOSTICS MARKET ANALYSIS BY END USER
    293. DIAGNOSTICS MARKET ANALYSIS BY REGIONAL
    294. MARKET ANALYSIS BY APPLICATION
    295. ANALYSIS BY TECHNOLOGY
    296. BY PRODUCT TYPE
    297. BY END USER
    298. INDONESIA MOLECULAR DIAGNOSTICS MARKET ANALYSIS BY REGIONAL
    299. REST OF APAC MOLECULAR DIAGNOSTICS MARKET ANALYSIS BY APPLICATION
    300. REST OF APAC MOLECULAR DIAGNOSTICS MARKET ANALYSIS BY TECHNOLOGY
    301. REST OF APAC MOLECULAR DIAGNOSTICS MARKET ANALYSIS BY PRODUCT TYPE
    302. REST OF APAC MOLECULAR DIAGNOSTICS MARKET ANALYSIS BY END USER
    303. REST OF APAC MOLECULAR DIAGNOSTICS MARKET ANALYSIS BY REGIONAL
    304. SOUTH AMERICA MOLECULAR DIAGNOSTICS MARKET ANALYSIS
    305. MOLECULAR DIAGNOSTICS MARKET ANALYSIS BY APPLICATION
    306. DIAGNOSTICS MARKET ANALYSIS BY TECHNOLOGY
    307. MARKET ANALYSIS BY PRODUCT TYPE
    308. ANALYSIS BY END USER
    309. BY REGIONAL
    310. MEXICO MOLECULAR DIAGNOSTICS MARKET ANALYSIS BY END USER
    311. MOLECULAR DIAGNOSTICS MARKET ANALYSIS BY REGIONAL
    312. DIAGNOSTICS MARKET ANALYSIS BY APPLICATION
    313. DIAGNOSTICS MARKET ANALYSIS BY TECHNOLOGY
    314. DIAGNOSTICS MARKET ANALYSIS BY PRODUCT TYPE
    315. DIAGNOSTICS MARKET ANALYSIS BY END USER
    316. MARKET ANALYSIS BY REGIONAL <

    Molecular Diagnostics Market Segmentation

    • Molecular Diagnostics Market By Application (USD Billion, 2019-2035)
      • Oncology
      • Infectious Diseases
      • Genetic Testing
      • Blood Screening
      • Other Applications
    • Molecular Diagnostics Market By Technology (USD Billion, 2019-2035)
      • Polymerase Chain Reaction
      • Next-Generation Sequencing
      • Microarrays
      • In Situ Hybridization
      • Other Technologies
    • Molecular Diagnostics Market By Product Type (USD Billion, 2019-2035)
      • Reagents
      • Instruments
      • Software
      • Consumables
      • Other Products
    • Molecular Diagnostics Market By End User (USD Billion, 2019-2035)
      • Hospitals
      • Diagnostic Laboratories
      • Academic Institutions
      • Pharmaceutical Companies
      • Other End Users
    • Molecular Diagnostics Market By Regional (USD Billion, 2019-2035)
      • North America
      • Europe
      • South America
      • Asia Pacific
      • Middle East and Africa

    Molecular Diagnostics Market Regional Outlook (USD Billion, 2019-2035)

    • North America Outlook (USD Billion, 2019-2035)
      • North America Molecular Diagnostics Market by Application Type
        • Oncology
        • Infectious Diseases
        • Genetic Testing
        • Blood Screening
        • Other Applications
      • North America Molecular Diagnostics Market by Technology Type
        • Polymerase Chain Reaction
        • Next-Generation Sequencing
        • Microarrays
        • In Situ Hybridization
        • Other Technologies
      • North America Molecular Diagnostics Market by Product Type
        • Reagents
        • Instruments
        • Software
        • Consumables
        • Other Products
      • North America Molecular Diagnostics Market by End User Type
        • Hospitals
        • Diagnostic Laboratories
        • Academic Institutions
        • Pharmaceutical Companies
        • Other End Users
      • North America Molecular Diagnostics Market by Regional Type
        • US
        • Canada
      • US Outlook (USD Billion, 2019-2035)
      • US Molecular Diagnostics Market by Application Type
        • Oncology
        • Infectious Diseases
        • Genetic Testing
        • Blood Screening
        • Other Applications
      • US Molecular Diagnostics Market by Technology Type
        • Polymerase Chain Reaction
        • Next-Generation Sequencing
        • Microarrays
        • In Situ Hybridization
        • Other Technologies
      • US Molecular Diagnostics Market by Product Type
        • Reagents
        • Instruments
        • Software
        • Consumables
        • Other Products
      • US Molecular Diagnostics Market by End User Type
        • Hospitals
        • Diagnostic Laboratories
        • Academic Institutions
        • Pharmaceutical Companies
        • Other End Users
      • CANADA Outlook (USD Billion, 2019-2035)
      • CANADA Molecular Diagnostics Market by Application Type
        • Oncology
        • Infectious Diseases
        • Genetic Testing
        • Blood Screening
        • Other Applications
      • CANADA Molecular Diagnostics Market by Technology Type
        • Polymerase Chain Reaction
        • Next-Generation Sequencing
        • Microarrays
        • In Situ Hybridization
        • Other Technologies
      • CANADA Molecular Diagnostics Market by Product Type
        • Reagents
        • Instruments
        • Software
        • Consumables
        • Other Products
      • CANADA Molecular Diagnostics Market by End User Type
        • Hospitals
        • Diagnostic Laboratories
        • Academic Institutions
        • Pharmaceutical Companies
        • Other End Users
      • Europe Outlook (USD Billion, 2019-2035)
        • Europe Molecular Diagnostics Market by Application Type
          • Oncology
          • Infectious Diseases
          • Genetic Testing
          • Blood Screening
          • Other Applications
        • Europe Molecular Diagnostics Market by Technology Type
          • Polymerase Chain Reaction
          • Next-Generation Sequencing
          • Microarrays
          • In Situ Hybridization
          • Other Technologies
        • Europe Molecular Diagnostics Market by Product Type
          • Reagents
          • Instruments
          • Software
          • Consumables
          • Other Products
        • Europe Molecular Diagnostics Market by End User Type
          • Hospitals
          • Diagnostic Laboratories
          • Academic Institutions
          • Pharmaceutical Companies
          • Other End Users
        • Europe Molecular Diagnostics Market by Regional Type
          • Germany
          • UK
          • France
          • Russia
          • Italy
          • Spain
          • Rest of Europe
        • GERMANY Outlook (USD Billion, 2019-2035)
        • GERMANY Molecular Diagnostics Market by Application Type
          • Oncology
          • Infectious Diseases
          • Genetic Testing
          • Blood Screening
          • Other Applications
        • GERMANY Molecular Diagnostics Market by Technology Type
          • Polymerase Chain Reaction
          • Next-Generation Sequencing
          • Microarrays
          • In Situ Hybridization
          • Other Technologies
        • GERMANY Molecular Diagnostics Market by Product Type
          • Reagents
          • Instruments
          • Software
          • Consumables
          • Other Products
        • GERMANY Molecular Diagnostics Market by End User Type
          • Hospitals
          • Diagnostic Laboratories
          • Academic Institutions
          • Pharmaceutical Companies
          • Other End Users
        • UK Outlook (USD Billion, 2019-2035)
        • UK Molecular Diagnostics Market by Application Type
          • Oncology
          • Infectious Diseases
          • Genetic Testing
          • Blood Screening
          • Other Applications
        • UK Molecular Diagnostics Market by Technology Type
          • Polymerase Chain Reaction
          • Next-Generation Sequencing
          • Microarrays
          • In Situ Hybridization
          • Other Technologies
        • UK Molecular Diagnostics Market by Product Type
          • Reagents
          • Instruments
          • Software
          • Consumables
          • Other Products
        • UK Molecular Diagnostics Market by End User Type
          • Hospitals
          • Diagnostic Laboratories
          • Academic Institutions
          • Pharmaceutical Companies
          • Other End Users
        • FRANCE Outlook (USD Billion, 2019-2035)
        • FRANCE Molecular Diagnostics Market by Application Type
          • Oncology
          • Infectious Diseases
          • Genetic Testing
          • Blood Screening
          • Other Applications
        • FRANCE Molecular Diagnostics Market by Technology Type
          • Polymerase Chain Reaction
          • Next-Generation Sequencing
          • Microarrays
          • In Situ Hybridization
          • Other Technologies
        • FRANCE Molecular Diagnostics Market by Product Type
          • Reagents
          • Instruments
          • Software
          • Consumables
          • Other Products
        • FRANCE Molecular Diagnostics Market by End User Type
          • Hospitals
          • Diagnostic Laboratories
          • Academic Institutions
          • Pharmaceutical Companies
          • Other End Users
        • RUSSIA Outlook (USD Billion, 2019-2035)
        • RUSSIA Molecular Diagnostics Market by Application Type
          • Oncology
          • Infectious Diseases
          • Genetic Testing
          • Blood Screening
          • Other Applications
        • RUSSIA Molecular Diagnostics Market by Technology Type
          • Polymerase Chain Reaction
          • Next-Generation Sequencing
          • Microarrays
          • In Situ Hybridization
          • Other Technologies
        • RUSSIA Molecular Diagnostics Market by Product Type
          • Reagents
          • Instruments
          • Software
          • Consumables
          • Other Products
        • RUSSIA Molecular Diagnostics Market by End User Type
          • Hospitals
          • Diagnostic Laboratories
          • Academic Institutions
          • Pharmaceutical Companies
          • Other End Users
        • ITALY Outlook (USD Billion, 2019-2035)
        • ITALY Molecular Diagnostics Market by Application Type
          • Oncology
          • Infectious Diseases
          • Genetic Testing
          • Blood Screening
          • Other Applications
        • ITALY Molecular Diagnostics Market by Technology Type
          • Polymerase Chain Reaction
          • Next-Generation Sequencing
          • Microarrays
          • In Situ Hybridization
          • Other Technologies
        • ITALY Molecular Diagnostics Market by Product Type
          • Reagents
          • Instruments
          • Software
          • Consumables
          • Other Products
        • ITALY Molecular Diagnostics Market by End User Type
          • Hospitals
          • Diagnostic Laboratories
          • Academic Institutions
          • Pharmaceutical Companies
          • Other End Users
        • SPAIN Outlook (USD Billion, 2019-2035)
        • SPAIN Molecular Diagnostics Market by Application Type
          • Oncology
          • Infectious Diseases
          • Genetic Testing
          • Blood Screening
          • Other Applications
        • SPAIN Molecular Diagnostics Market by Technology Type
          • Polymerase Chain Reaction
          • Next-Generation Sequencing
          • Microarrays
          • In Situ Hybridization
          • Other Technologies
        • SPAIN Molecular Diagnostics Market by Product Type
          • Reagents
          • Instruments
          • Software
          • Consumables
          • Other Products
        • SPAIN Molecular Diagnostics Market by End User Type
          • Hospitals
          • Diagnostic Laboratories
          • Academic Institutions
          • Pharmaceutical Companies
          • Other End Users
        • REST OF EUROPE Outlook (USD Billion, 2019-2035)
        • REST OF EUROPE Molecular Diagnostics Market by Application Type
          • Oncology
          • Infectious Diseases
          • Genetic Testing
          • Blood Screening
          • Other Applications
        • REST OF EUROPE Molecular Diagnostics Market by Technology Type
          • Polymerase Chain Reaction
          • Next-Generation Sequencing
          • Microarrays
          • In Situ Hybridization
          • Other Technologies
        • REST OF EUROPE Molecular Diagnostics Market by Product Type
          • Reagents
          • Instruments
          • Software
          • Consumables
          • Other Products
        • REST OF EUROPE Molecular Diagnostics Market by End User Type
          • Hospitals
          • Diagnostic Laboratories
          • Academic Institutions
          • Pharmaceutical Companies
          • Other End Users
        • APAC Outlook (USD Billion, 2019-2035)
          • APAC Molecular Diagnostics Market by Application Type
            • Oncology
            • Infectious Diseases
            • Genetic Testing
            • Blood Screening
            • Other Applications
          • APAC Molecular Diagnostics Market by Technology Type
            • Polymerase Chain Reaction
            • Next-Generation Sequencing
            • Microarrays
            • In Situ Hybridization
            • Other Technologies
          • APAC Molecular Diagnostics Market by Product Type
            • Reagents
            • Instruments
            • Software
            • Consumables
            • Other Products
          • APAC Molecular Diagnostics Market by End User Type
            • Hospitals
            • Diagnostic Laboratories
            • Academic Institutions
            • Pharmaceutical Companies
            • Other End Users
          • APAC Molecular Diagnostics Market by Regional Type
            • China
            • India
            • Japan
            • South Korea
            • Malaysia
            • Thailand
            • Indonesia
            • Rest of APAC
          • CHINA Outlook (USD Billion, 2019-2035)
          • CHINA Molecular Diagnostics Market by Application Type
            • Oncology
            • Infectious Diseases
            • Genetic Testing
            • Blood Screening
            • Other Applications
          • CHINA Molecular Diagnostics Market by Technology Type
            • Polymerase Chain Reaction
            • Next-Generation Sequencing
            • Microarrays
            • In Situ Hybridization
            • Other Technologies
          • CHINA Molecular Diagnostics Market by Product Type
            • Reagents
            • Instruments
            • Software
            • Consumables
            • Other Products
          • CHINA Molecular Diagnostics Market by End User Type
            • Hospitals
            • Diagnostic Laboratories
            • Academic Institutions
            • Pharmaceutical Companies
            • Other End Users
          • INDIA Outlook (USD Billion, 2019-2035)
          • INDIA Molecular Diagnostics Market by Application Type
            • Oncology
            • Infectious Diseases
            • Genetic Testing
            • Blood Screening
            • Other Applications
          • INDIA Molecular Diagnostics Market by Technology Type
            • Polymerase Chain Reaction
            • Next-Generation Sequencing
            • Microarrays
            • In Situ Hybridization
            • Other Technologies
          • INDIA Molecular Diagnostics Market by Product Type
            • Reagents
            • Instruments
            • Software
            • Consumables
            • Other Products
          • INDIA Molecular Diagnostics Market by End User Type
            • Hospitals
            • Diagnostic Laboratories
            • Academic Institutions
            • Pharmaceutical Companies
            • Other End Users
          • JAPAN Outlook (USD Billion, 2019-2035)
          • JAPAN Molecular Diagnostics Market by Application Type
            • Oncology
            • Infectious Diseases
            • Genetic Testing
            • Blood Screening
            • Other Applications
          • JAPAN Molecular Diagnostics Market by Technology Type
            • Polymerase Chain Reaction
            • Next-Generation Sequencing
            • Microarrays
            • In Situ Hybridization
            • Other Technologies
          • JAPAN Molecular Diagnostics Market by Product Type
            • Reagents
            • Instruments
            • Software
            • Consumables
            • Other Products
          • JAPAN Molecular Diagnostics Market by End User Type
            • Hospitals
            • Diagnostic Laboratories
            • Academic Institutions
            • Pharmaceutical Companies
            • Other End Users
          • SOUTH KOREA Outlook (USD Billion, 2019-2035)
          • SOUTH KOREA Molecular Diagnostics Market by Application Type
            • Oncology
            • Infectious Diseases
            • Genetic Testing
            • Blood Screening
            • Other Applications
          • SOUTH KOREA Molecular Diagnostics Market by Technology Type
            • Polymerase Chain Reaction
            • Next-Generation Sequencing
            • Microarrays
            • In Situ Hybridization
            • Other Technologies
          • SOUTH KOREA Molecular Diagnostics Market by Product Type
            • Reagents
            • Instruments
            • Software
            • Consumables
            • Other Products
          • SOUTH KOREA Molecular Diagnostics Market by End User Type
            • Hospitals
            • Diagnostic Laboratories
            • Academic Institutions
            • Pharmaceutical Companies
            • Other End Users
          • MALAYSIA Outlook (USD Billion, 2019-2035)
          • MALAYSIA Molecular Diagnostics Market by Application Type
            • Oncology
            • Infectious Diseases
            • Genetic Testing
            • Blood Screening
            • Other Applications
          • MALAYSIA Molecular Diagnostics Market by Technology Type
            • Polymerase Chain Reaction
            • Next-Generation Sequencing
            • Microarrays
            • In Situ Hybridization
            • Other Technologies
          • MALAYSIA Molecular Diagnostics Market by Product Type
            • Reagents
            • Instruments
            • Software
            • Consumables
            • Other Products
          • MALAYSIA Molecular Diagnostics Market by End User Type
            • Hospitals
            • Diagnostic Laboratories
            • Academic Institutions
            • Pharmaceutical Companies
            • Other End Users
          • THAILAND Outlook (USD Billion, 2019-2035)
          • THAILAND Molecular Diagnostics Market by Application Type
            • Oncology
            • Infectious Diseases
            • Genetic Testing
            • Blood Screening
            • Other Applications
          • THAILAND Molecular Diagnostics Market by Technology Type
            • Polymerase Chain Reaction
            • Next-Generation Sequencing
            • Microarrays
            • In Situ Hybridization
            • Other Technologies
          • THAILAND Molecular Diagnostics Market by Product Type
            • Reagents
            • Instruments
            • Software
            • Consumables
            • Other Products
          • THAILAND Molecular Diagnostics Market by End User Type
            • Hospitals
            • Diagnostic Laboratories
            • Academic Institutions
            • Pharmaceutical Companies
            • Other End Users
          • INDONESIA Outlook (USD Billion, 2019-2035)
          • INDONESIA Molecular Diagnostics Market by Application Type
            • Oncology
            • Infectious Diseases
            • Genetic Testing
            • Blood Screening
            • Other Applications
          • INDONESIA Molecular Diagnostics Market by Technology Type
            • Polymerase Chain Reaction
            • Next-Generation Sequencing
            • Microarrays
            • In Situ Hybridization
            • Other Technologies
          • INDONESIA Molecular Diagnostics Market by Product Type
            • Reagents
            • Instruments
            • Software
            • Consumables
            • Other Products
          • INDONESIA Molecular Diagnostics Market by End User Type
            • Hospitals
            • Diagnostic Laboratories
            • Academic Institutions
            • Pharmaceutical Companies
            • Other End Users
          • REST OF APAC Outlook (USD Billion, 2019-2035)
          • REST OF APAC Molecular Diagnostics Market by Application Type
            • Oncology
            • Infectious Diseases
            • Genetic Testing
            • Blood Screening
            • Other Applications
          • REST OF APAC Molecular Diagnostics Market by Technology Type
            • Polymerase Chain Reaction
            • Next-Generation Sequencing
            • Microarrays
            • In Situ Hybridization
            • Other Technologies
          • REST OF APAC Molecular Diagnostics Market by Product Type
            • Reagents
            • Instruments
            • Software
            • Consumables
            • Other Products
          • REST OF APAC Molecular Diagnostics Market by End User Type
            • Hospitals
            • Diagnostic Laboratories
            • Academic Institutions
            • Pharmaceutical Companies
            • Other End Users
          • South America Outlook (USD Billion, 2019-2035)
            • South America Molecular Diagnostics Market by Application Type
              • Oncology
              • Infectious Diseases
              • Genetic Testing
              • Blood Screening
              • Other Applications
            • South America Molecular Diagnostics Market by Technology Type
              • Polymerase Chain Reaction
              • Next-Generation Sequencing
              • Microarrays
              • In Situ Hybridization
              • Other Technologies
            • South America Molecular Diagnostics Market by Product Type
              • Reagents
              • Instruments
              • Software
              • Consumables
              • Other Products
            • South America Molecular Diagnostics Market by End User Type
              • Hospitals
              • Diagnostic Laboratories
              • Academic Institutions
              • Pharmaceutical Companies
              • Other End Users
            • South America Molecular Diagnostics Market by Regional Type
              • Brazil
              • Mexico
              • Argentina
              • Rest of South America
            • BRAZIL Outlook (USD Billion, 2019-2035)
            • BRAZIL Molecular Diagnostics Market by Application Type
              • Oncology
              • Infectious Diseases
              • Genetic Testing
              • Blood Screening
              • Other Applications
            • BRAZIL Molecular Diagnostics Market by Technology Type
              • Polymerase Chain Reaction
              • Next-Generation Sequencing
              • Microarrays
              • In Situ Hybridization
              • Other Technologies
            • BRAZIL Molecular Diagnostics Market by Product Type
              • Reagents
              • Instruments
              • Software
              • Consumables
              • Other Products
            • BRAZIL Molecular Diagnostics Market by End User Type
              • Hospitals
              • Diagnostic Laboratories
              • Academic Institutions
              • Pharmaceutical Companies
              • Other End Users
            • MEXICO Outlook (USD Billion, 2019-2035)
            • MEXICO Molecular Diagnostics Market by Application Type
              • Oncology
              • Infectious Diseases
              • Genetic Testing
              • Blood Screening
              • Other Applications
            • MEXICO Molecular Diagnostics Market by Technology Type
              • Polymerase Chain Reaction
              • Next-Generation Sequencing
              • Microarrays
              • In Situ Hybridization
              • Other Technologies
            • MEXICO Molecular Diagnostics Market by Product Type
              • Reagents
              • Instruments
              • Software
              • Consumables
              • Other Products
            • MEXICO Molecular Diagnostics Market by End User Type
              • Hospitals
              • Diagnostic Laboratories
              • Academic Institutions
              • Pharmaceutical Companies
              • Other End Users
            • ARGENTINA Outlook (USD Billion, 2019-2035)
            • ARGENTINA Molecular Diagnostics Market by Application Type
              • Oncology
              • Infectious Diseases
              • Genetic Testing
              • Blood Screening
              • Other Applications
            • ARGENTINA Molecular Diagnostics Market by Technology Type
              • Polymerase Chain Reaction
              • Next-Generation Sequencing
              • Microarrays
              • In Situ Hybridization
              • Other Technologies
            • ARGENTINA Molecular Diagnostics Market by Product Type
              • Reagents
              • Instruments
              • Software
              • Consumables
              • Other Products
            • ARGENTINA Molecular Diagnostics Market by End User Type
              • Hospitals
              • Diagnostic Laboratories
              • Academic Institutions
              • Pharmaceutical Companies
              • Other End Users
            • REST OF SOUTH AMERICA Outlook (USD Billion, 2019-2035)
            • REST OF SOUTH AMERICA Molecular Diagnostics Market by Application Type
              • Oncology
              • Infectious Diseases
              • Genetic Testing
              • Blood Screening
              • Other Applications
            • REST OF SOUTH AMERICA Molecular Diagnostics Market by Technology Type
              • Polymerase Chain Reaction
              • Next-Generation Sequencing
              • Microarrays
              • In Situ Hybridization
              • Other Technologies
            • REST OF SOUTH AMERICA Molecular Diagnostics Market by Product Type
              • Reagents
              • Instruments
              • Software
              • Consumables
              • Other Products
            • REST OF SOUTH AMERICA Molecular Diagnostics Market by End User Type
              • Hospitals
              • Diagnostic Laboratories
              • Academic Institutions
              • Pharmaceutical Companies
              • Other End Users
            • MEA Outlook (USD Billion, 2019-2035)
              • MEA Molecular Diagnostics Market by Application Type
                • Oncology
                • Infectious Diseases
                • Genetic Testing
                • Blood Screening
                • Other Applications
              • MEA Molecular Diagnostics Market by Technology Type
                • Polymerase Chain Reaction
                • Next-Generation Sequencing
                • Microarrays
                • In Situ Hybridization
                • Other Technologies
              • MEA Molecular Diagnostics Market by Product Type
                • Reagents
                • Instruments
                • Software
                • Consumables
                • Other Products
              • MEA Molecular Diagnostics Market by End User Type
                • Hospitals
                • Diagnostic Laboratories
                • Academic Institutions
                • Pharmaceutical Companies
                • Other End Users
              • MEA Molecular Diagnostics Market by Regional Type
                • GCC Countries
                • South Africa
                • Rest of MEA
              • GCC COUNTRIES Outlook (USD Billion, 2019-2035)
              • GCC COUNTRIES Molecular Diagnostics Market by Application Type
                • Oncology
                • Infectious Diseases
                • Genetic Testing
                • Blood Screening
                • Other Applications
              • GCC COUNTRIES Molecular Diagnostics Market by Technology Type
                • Polymerase Chain Reaction
                • Next-Generation Sequencing
                • Microarrays
                • In Situ Hybridization
                • Other Technologies
              • GCC COUNTRIES Molecular Diagnostics Market by Product Type
                • Reagents
                • Instruments
                • Software
                • Consumables
                • Other Products
              • GCC COUNTRIES Molecular Diagnostics Market by End User Type
                • Hospitals
                • Diagnostic Laboratories
                • Academic Institutions
                • Pharmaceutical Companies
                • Other End Users
              • SOUTH AFRICA Outlook (USD Billion, 2019-2035)
              • SOUTH AFRICA Molecular Diagnostics Market by Application Type
                • Oncology
                • Infectious Diseases
                • Genetic Testing
                • Blood Screening
                • Other Applications
              • SOUTH AFRICA Molecular Diagnostics Market by Technology Type
                • Polymerase Chain Reaction
                • Next-Generation Sequencing
                • Microarrays
                • In Situ Hybridization
                • Other Technologies
              • SOUTH AFRICA Molecular Diagnostics Market by Product Type
                • Reagents
                • Instruments
                • Software
                • Consumables
                • Other Products
              • SOUTH AFRICA Molecular Diagnostics Market by End User Type
                • Hospitals
                • Diagnostic Laboratories
                • Academic Institutions
                • Pharmaceutical Companies
                • Other End Users
              • REST OF MEA Outlook (USD Billion, 2019-2035)
              • REST OF MEA Molecular Diagnostics Market by Application Type
                • Oncology
                • Infectious Diseases
                • Genetic Testing
                • Blood Screening
                • Other Applications
              • REST OF MEA Molecular Diagnostics Market by Technology Type
                • Polymerase Chain Reaction
                • Next-Generation Sequencing
                • Microarrays
                • In Situ Hybridization
                • Other Technologies
              • REST OF MEA Molecular Diagnostics Market by Product Type
                • Reagents
                • Instruments
                • Software
                • Consumables
                • Other Products
              • REST OF MEA Molecular Diagnostics Market by End User Type
                • Hospitals
                • Diagnostic Laboratories
                • Academic Institutions
                • Pharmaceutical Companies
                • Other End Users

     

     

    Molecular Diagnostics Market Research Report - Forecast till 2035 Infographic
    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Related Reports

    No regional reports available for this market.

    No country-specific reports available for this market.

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne Founder
    Case Study

    Chemicals and Materials

    Global Magnesium Sulfate Market – Forecast till 2027